NewAmsterdam Pharma (NAMS) Short Interest Ratio & Short Volume → America’s worst nightmare? (From Porter & Company) (Ad) Free NAMS Stock Alerts $20.21 -1.22 (-5.69%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media NewAmsterdam Pharma Short Interest DataCurrent Short Volume375,000 sharesPrevious Short Volume335,200 sharesChange Vs. Previous Month+11.87%Dollar Volume Sold Short$8.18 millionShort Interest Ratio / Days to Cover1.7Last Record DateApril 30, 2024Outstanding Shares89,270,000 sharesFloat Size39,250,000 sharesShort Percent of Float0.96%Today's Trading Volume107,664 sharesAverage Trading Volume222,235 sharesToday's Volume Vs. Average48% Short Selling NewAmsterdam Pharma ? Sign up to receive the latest short interest report for NewAmsterdam Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNAMS Short Interest Over TimeNAMS Days to Cover Over TimeNAMS Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. NewAmsterdam Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024375,000 shares $8.18 million +11.9%1.0%1.7 $21.81 4/15/2024335,200 shares $6.62 million -0.8%0.9%1.4 $19.74 3/31/2024337,900 shares $7.99 million -1.9%0.9%1.4 $23.65 3/15/2024344,600 shares $7.59 million -6.0%1.0%1.5 $22.03 2/29/2024366,700 shares $8.38 million +38.3%1.1%1.7 $22.84 2/15/2024265,200 shares $5.22 million -2.7%0.8%1.3 $19.67 Get the Latest News and Ratings for NAMS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024272,500 shares $5.58 million -44.0%0.8%1.8 $20.47 1/15/2024486,200 shares $8.52 million +16.0%1.5%3.1 $17.53 12/31/2023419,300 shares $4.68 million -1.9%1.3%3.8 $11.17 12/15/2023427,500 shares $4.59 million +114.7%1.2%3.9 $10.74 11/30/2023199,100 shares $1.94 million -3.8%0.6%1.7 $9.76 11/15/2023206,900 shares $2.06 million -43.8%0.6%2.1 $9.95 10/31/2023367,800 shares $3.31 million +267.8%1.1%2.6 $9.00 10/15/2023100,000 shares $725,000.00 -72.7%0.3%0.9 $7.25 9/30/2023366,200 shares $3.39 million +12.1%1.1%3.5 $9.25 9/15/2023326,700 shares $3.27 million +1.0%1.0%3.2 $10.00 8/31/2023323,600 shares $3.34 million -0.5%0.9%3.2 $10.31 8/15/2023325,100 shares $3.58 million +29.7%0.9%3 $11.00 7/31/2023250,700 shares $2.89 million -0.4%0.7%3.7 $11.52 7/15/2023251,700 shares $3.01 million -12.7%0.7%3.6 $11.96 6/30/2023288,400 shares $3.43 million +53.3%0.8%4.2 $11.89 6/15/2023188,100 shares $2.29 million +3.2%0.5%3.1 $12.17 5/31/2023182,200 shares $2.53 million -47.5%0.6%3.9 $13.86 5/15/2023347,300 shares $4.29 million No Change1.1%10.2 $12.34 NAMS Short Interest - Frequently Asked Questions What is NewAmsterdam Pharma's current short interest? Short interest is the volume of NewAmsterdam Pharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 375,000 shares of NAMS short. 0.96% of NewAmsterdam Pharma's shares are currently sold short. Learn More on NewAmsterdam Pharma's current short interest. What is a good short interest ratio for NewAmsterdam Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NAMS shares currently have a short interest ratio of 2.0. Learn More on NewAmsterdam Pharma's short interest ratio. What is a good short interest percentage for NewAmsterdam Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.96% of NewAmsterdam Pharma's floating shares are currently sold short. Is NewAmsterdam Pharma's short interest increasing or decreasing? NewAmsterdam Pharma saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 375,000 shares, an increase of 11.9% from the previous total of 335,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NewAmsterdam Pharma's float size? NewAmsterdam Pharma currently has issued a total of 89,270,000 shares. Some of NewAmsterdam Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NewAmsterdam Pharma currently has a public float of 39,250,000 shares. How does NewAmsterdam Pharma's short interest compare to its competitors? 0.96% of NewAmsterdam Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to NewAmsterdam Pharma: Syndax Pharmaceuticals, Inc. (11.90%), Edgewise Therapeutics, Inc. (10.36%), Galapagos NV (2.41%), Amneal Pharmaceuticals, Inc. (2.31%), Agios Pharmaceuticals, Inc. (11.77%), Structure Therapeutics Inc. (10.35%), Amphastar Pharmaceuticals, Inc. (11.35%), Evotec SE (0.05%), Deciphera Pharmaceuticals, Inc. (11.65%), Catalyst Pharmaceuticals, Inc. (7.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short NewAmsterdam Pharma stock? Short selling NAMS is an investing strategy that aims to generate trading profit from NewAmsterdam Pharma as its price is falling. NAMS shares are trading down $1.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NewAmsterdam Pharma? A short squeeze for NewAmsterdam Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NAMS, which in turn drives the price of the stock up even further. How often is NewAmsterdam Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NAMS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SNDX Short Interest Data EWTX Short Interest Data GLPG Short Interest Data AMRX Short Interest Data AGIO Short Interest Data GPCR Short Interest Data AMPH Short Interest Data EVO Short Interest Data DCPH Short Interest Data CPRX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NAMS) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders